Lv1
60 积分 2024-03-05 加入
FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical Data
12小时前
待确认
RNA Interference With Zilebesiran for Mild to Moderate Hypertension
28天前
已完结
Key considerations in the preclinical development of biosimilars
1个月前
已完结
Considerations for Assessment of Reproductive and Developmental Toxicity of Oligonucleotide-Based Therapeutics
1个月前
已完结
Validation for soluble C5b-9 detection and comparative analysis of three quantification methods
2个月前
已完结
Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice
2个月前
已完结
Considerations for Assessment of Reproductive and Developmental Toxicity of Oligonucleotide-Based Therapeutics
2个月前
已完结
Recommendations for Safety Pharmacology Evaluations of Oligonucleotide-Based Therapeutics
2个月前
已完结
Considerations for the Characterization and Interpretation of Results Related to Alternative Complement Activation in Monkeys Associated with Oligonucleotide-Based Therapeutics
2个月前
已完结
OSWG Recommendations for Genotoxicity Testing of Novel Oligonucleotide-Based Therapeutics
2个月前
已完结
皖公网安备34019202002308
